2023
DOI: 10.1016/j.biopha.2023.114520
|View full text |Cite
|
Sign up to set email alerts
|

Multimodal study of CHI3L1 inhibition and its effect on angiogenesis, migration, immune response and refractive index of cellular structures in glioblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 80 publications
0
4
0
Order By: Relevance
“…E-cadherin (mouse monoclonal, 1:1000, sc-8426, Santa Cruz), N-cadherin (mouse monoclonal, 1:1000, sc-8424, Santa Cruz), β-tubulin (rabbit polyclonal, 1:1000, ab6046, in 0.1% BSA in 0. 1% TBST, ab6046, Abcam, Cambridge, UK), VEGFA (mouse monoclonal, 1:1000, M7273, Dako, Glostrup, Denmark), VEGFC (mouse monoclonal, 101-M90, ReliaTech, Wolfenbüttel, Germany), VEGFD (mouse monoclonal, MAB286, R&D) [7].…”
Section: Western Blotmentioning
confidence: 99%
See 2 more Smart Citations
“…E-cadherin (mouse monoclonal, 1:1000, sc-8426, Santa Cruz), N-cadherin (mouse monoclonal, 1:1000, sc-8424, Santa Cruz), β-tubulin (rabbit polyclonal, 1:1000, ab6046, in 0.1% BSA in 0. 1% TBST, ab6046, Abcam, Cambridge, UK), VEGFA (mouse monoclonal, 1:1000, M7273, Dako, Glostrup, Denmark), VEGFC (mouse monoclonal, 101-M90, ReliaTech, Wolfenbüttel, Germany), VEGFD (mouse monoclonal, MAB286, R&D) [7].…”
Section: Western Blotmentioning
confidence: 99%
“…THP-1 cells were cultured for 24 hours in complete RPMI-1640 medium (Gibco), supplemented with 100 nM PMA (phorbol 12-myristate 13-acetate) (Sigma-Aldrich) [28], [7]. Subsequently, adherent macrophages were identi ed at the bottom of the vessel.…”
Section: Monocyte Differentiationmentioning
confidence: 99%
See 1 more Smart Citation
“…Antibody-based therapies also facilitate the immune-mediated clearance of CHI3L1 (YKL40)-expressing cancer cells. In vitro studies have demonstrated that CHI3L1 (YKL40) inhibition may have an influence on angiogenesis, migration, and immune response in various tumor cells [ 71 , 85 ]. However, the complexity, heterogeneity, and various molecular pathways all contribute to cancer development and the therapeutic response in the tumor microenvironment.…”
Section: Chi3l1 (Ykl40)—related Therapymentioning
confidence: 99%
“…The risk of HCC in autoimmune hepatitis is lower than that of other chronic liver diseases. A long-term follow-up study based on 1,428 patients with autoimmune hepatitis (AIH) found that only 1.7% of patients developed HCC with cirrhosis, only mildly increased the risk of HCC (80). Clinical and basic research on autoimmune liver disease in China has just begun, and there is a lack of relevant epidemiologic information, resulting in serious clinical underdiagnosis and mistreatment.…”
Section: Other Liver Diseasesmentioning
confidence: 99%